Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.31

CBIOCrescent Biopharma, Inc.

$334M

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M

Gross Profit

$4M97.8% margin

Operating Income

-$6M-159.5% margin

Net Income

-$6M-160.3% margin

EPS (Diluted)

$-5.11

Cash Flow

Operating Cash Flow

$14M

Free Cash Flow

$14M

Stock-Based Comp.

$376,243

Balance Sheet

Total Assets

$29M

Total Liabilities

$20M

Stockholders' Equity

$8M

Cash & Equivalents

$28M

← FY 2012 All Quarters

CBIO FY 2011 Earnings — Crescent Biopharma, Inc. Revenue & Financial Results | Market Cap Arena